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Abstract 
Background: Allogeneic red blood cell transfusions (ABT) are common in older hip fracture patients. Recent research 
supports a restrictive transfusion policy. The aim was to study variation in hemoglobin (Hb) concentration, and clinical 
outcomes in these patients.
Results: Cross-sectional study with one-year follow-up in an orthogeriatric unit. Data were obtained from a qual-
ity register with demographic and medical information collected by an interdisciplinary team. 106 (22 %) of the 491 
patients admitted from September 2011 throughout September 2012 (76 % women, mean age 85 years) received 
ABT. When given ABT, 80 % had Hb <80 g/l and mean Hb was 78 g/l. Mean Hb, regardless ABT, showed variation from 
125 g/l (±16) on admission to 106 g/l (±17), 101 g/l (±16) and 102 g/l (±14) on 1st, 3rd and 5th postoperative day 
respectively. Patients with per-/subtrochanteric fractures more often received ABT than those with femur neck frac-
tures (p < 0.001), 70 % of the patients receiving ABT had a per-/subtrochanteric fracture. Patients who received ABT 
were older, had more chronic diseases and lower mean Hb throughout the hospital stay. Length of stay was longer 
(median 7 vs. 6 days, p = 0.01), and medical complications more common. In-hospital and 30-day mortalities were 
similar in patients given ABT and in those who were not, but 1-year mortality was higher among patients who were 
given ABT (p = 0.008).
Conclusions: Hb had a tendency to fall during the three first days after surgery and seemed to be stabilized on day 
5. Patients who received ABT had poorer health, but not significantly higher short-term mortality. This study demon-
strates a restrictive transfusion policy.
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Background
Older patients with hip fractures represent an important 
and large group of in-patients in acute hospitals. Oslo, 
Norway has the highest reported incidence of hip frac-
tures in the world [1, 2]. In a government report on acute 
medical care in Norway, hip fractures were listed as the 
most common cause of admission for acute hospital care 
among individuals aged 90 years and older [3].
In spite of improved care with a multidisciplinary 
approach [4], the prognosis regarding loss of function 
and 1-year survival is poor [5]. The patients are complex 
and many factors contribute to the prognosis. One con-
tributing factor is the patients’ hemoglobin concentration 
(Hb). There are many reasons for low Hb in hip fracture 
patients, including acute blood loss from the fracture, but 
also chronic or more acute anemia is common among 
old and multi-morbid patients [6]. Patients are com-
monly given allogeneic red blood cell transfusion (ABT) 
when hospitalized for a hip fracture [7, 8]. However, 
recent reviews of best practice for the management of 
older persons with hip fracture [9, 10] and guidelines for 
care of older hip fracture patients only address this issue 
briefly. In a recent multicenter randomized controlled 
study comparing a liberal transfusion policy at Hb below 
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100 grams per liter (g/l) with a more restrictive policy 
of below 80 g/l in hip fracture patients, no difference in 
mortality, in-hospital morbidity or in ability to walk inde-
pendently on 60-day follow-up could be seen [11]. This 
is in line with a Cochrane review on transfusion thresh-
olds and other strategies for guiding ABT [12]. A recent 
Danish study showed no difference in mobility after hip 
fracture, but reduced incidence of cardiovascular com-
plications and mortality with a liberal transfusion policy 
[13]. Clinical practice guidelines for red blood cell trans-
fusion recently published, recommend a restrictive policy 
for transfusions [14]. However, there is still no consensus 
regarding threshold values or when the changes in post-
operative Hb happens and when it is stabilized. Char-
acteristics of the patients who receive ABT are poorly 
studied.
In our orthogeriatric unit, we have a quality registry 
of the total population of older (65+ years) hip fracture 
patients, where patient data are collected in the aim 
of quality control. This registry enables us to observe 
characteristics and outcomes of patients according to 
our ABT practice. The aim of this study was to describe 
temporal changes in Hb concentration, describe clini-
cal characteristics of patients receiving blood transfu-
sion and compare clinical outcomes of patients receiving 
blood transfusions with those not receiving blood trans-
fusion in a non-selected population of older patients 
undergoing hip fracture surgery.
Methods
Design and setting
This was a cross sectional study with one-year follow-up, 
based on routine data used for quality improvement in an 
orthogeriatric unit for patients aged ≥65 years with hip 
fractures. The unit covers a population of approximately 
330,000 inhabitants, more than half of the population of 
Oslo. It is organized in the Department of surgery and 
has 18 ordinary beds including four observation beds for 
preoperative care. Principles and organization of care, 
staffing and general patient characteristics have been 
published previously [7]. In our unit, the general rou-
tine was to give blood transfusion at Hb concentrations 
below 80  g/l both before and after surgery. However, if 
the patients had symptoms of delirium or heart disease, a 
more liberal approach was taken.
Data collection
The current analyses were restricted to patients admitted 
between September 1st 2011 and September 30th 2012. 
All patients were 65  years or older and diagnosed with 
proximal femur fractures (S72.0–S72.2 according to ICD-
10). The interdisciplinary team collected all data dur-
ing routine care, and a registration form was completed 
during interdisciplinary ward meetings. The data were 
Coded and transferred into a database. Severity of 
comorbidity was scored according to the American Soci-
ety of Anesthesiologists (ASA) score by anesthesiologists. 
The score ranges from one (healthy) to five (moribund). 
Orthopedic surgeons registered type of fracture, surgical 
procedure and waiting time from admission to surgery, 
while a geriatrician registered medical comorbidities and 
complications during stay in hospital such as delirium, 
urinary tract infection, pressure ulcer, respiratory tract 
infection and surgical wound infection were registered 
by the whole team. Medical comorbidities were classi-
fied according to Charlson’s Co-morbidity index of 17 
items [15]. Demographic variables (age and gender) and 
information on whether the patient received ABT were 
collected from patients’ records. Hb was routinely ana-
lyzed on admission, the first, third and fifth post-opera-
tive day. Anemia was defined as Hb <130 g/l for men and 
Hb <120 g/l for women. Delirium was detected by nurses’ 
observation on each shift (three per day) using the Con-
fusion Assessment Method (CAM) [16]. Length of stay 
(LOS), need of nursing home admission and in-hospital 
mortality were recorded at discharge, while 30-days and 
1-year mortality of all causes was obtained from the 
patient administration system, provided by the National 
Population Registry.
Statistics
Continuous variables are presented as mean and standard 
deviation (SD), and categorical variables are presented as 
counts and percentages. Receiving ABT was treated as 
an outcome variable when studying patient characteris-
tics associated with ABT, and as an explanatory variable 
for postoperative complications and mortality. ABT was 
treated as a dichotomous variable whether outcome or 
explanatory. One-way analysis of variance and Chi square 
tests were performed to compare characteristics of those 
who received ABT with those who did not. Non-para-
metric tests were used to compare LOS. Patients who 
died in hospital (n = 8) were not included in the analyses 
including LOS. Binary regression analyses yielding risk 
ratios (RR) was used to identify factors associated with 
blood transfusion. Adjustments were made for age, ASA 
and comorbidity when comparing LOS. Due to the rela-
tively high prevalence of ABT (22 %), risk ratios of ABT 
according to categories of baseline characteristics were 
estimated in a binomial regression model [17], using the 
‘binreg’ command with “rr-option” in Stata. This regres-
sion model was also used to estimate risk ratios for post-
operative complications and death according to ABT. 
Additional analyses were adjusted for age (counts), ASA 
score (≥3 vs.  ≤2) and number of comorbid conditions 
(counts), and number of complications (counts).
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The significance level (alpha) was set to 0.05. Data were 
analyzed using SPSS version 20.0 (SPSS Inc., Chicago, IL) 
and Stata 11.1.
Ethics
This paper is based on a quality register containing rou-
tine data established for quality improvement purposes. 
No experimental intervention was performed. All data 
were Coded when transferred into the database. Ethical 
approval for this study was given by the Research Board 
of Diakonhjemmet Hospital. The patients were not asked 
to give informed consent. The Privacy Ombudsman for 
Research approved the database.
Results
Characteristics of patients receiving ABT compared 
with those who did not
A total of 491 patients, 371 women (76 %), with a mean age 
of 85 years (range 65–103) were included. Hb was meas-
ured on all four points for 214 patients. 155 patients were 
discharged before day 5 and 4 patients died within the fifth 
day. In the remaining patients Hb were not measured on 
day 3 and/or 5, however, for some of them on other days. 
On admission Hb were measured in 490 patients, mean 
Hb was 125 g/l (range 73–183, ±16), and 61 (51 %) of the 
men and 127 (34 %) of the women had anemia.
Mean Hb on the first postoperative day (n  =  477) 
was 106  g/l (range 44–150,  ±17), on the third postop-
erative day (n = 241) it was 101 g/l (range 63–148, ±16) 
(n  =  304), and on day five it was stabilized at 102  g/l 
(range 71–145, ±14).
In total 106 patients (22.0  %) received ABT. Eighty 
(75.5 %) of these received two units of red blood cell con-
centrate, nine (8.5 %) received one unit and 17 (16.0 %) 
received three units or more. One patient refused blood 
transfusion despite low Hb concentration due to religion. 
Prevalence and risk ratio of receiving ABT according to 
characteristics of the.
patients are shown in Table  1. There were no differ-
ences in gender or ASA score. However, patients who 
received ABT were older, had a higher Charlson’s index 
than those who did not [mean 1.3 (±1.1) vs. 1.1 (±1.0), 
p = 0.022], and a higher proportion of those with per-/
subtrochanteric fractures received blood than those with 
neck of femur fracture (Table 1).
Patients who received ABT had lower Hb concentration 
on admission; median 117  g/l (IQR 107,128) vs. 130  g/l 
(IQR 121, 138), Despite given blood transfusion Hb 
remained significantly lower (p < 0.001) in these patients, 
although it approached the levels of the non-transfused 
patients on the fifth postoperative day (Fig. 1a, b).
Most patients who received ABT had their lowest Hb 
value  ≤80  g/l, but one-fifth (21 patients) of those who 
received ABT had Hb  >80  g/l at its lowest. Only five 
patients who received ABT had Hb over 90 g/l and none 
over 100 g/l. Two patients received ABT before surgery, 
25 patients (24 %) on day one, 22 (21 %) on day two, 23 
(22 %) on day three, and 15 (14 %) received ABT on day 
four or later after surgery. Only one patient received 
blood transfusion during surgery. Sixteen patients 
(14.8  %) received ABT more than once during the hos-
pital stay.
Table 1 Prevalence and risk ratio of receiving allogeneic blood transfusion (ABT) according to characteristics of older hip 
fracture patients (n = 491)
Received ABT  
(n = 106)
No ABT  
(n = 385)




 Women 85 (22.9) 286 (77.1) 1.00 (ref.) 0.13
 Men 21 (17.5) 99 (82.5) 0.73 (0.48–1.12)
Age, n (%)
 <80 years 13 (11.0) 105 (89.0) 1.00 (ref.) 0.001
 ≥80 years 93 (24.9) 280 (75.1) 2.36 (1.37–4.05)
ASA score (n = 483), n (%)
 Low (1–2) 37 (18.1) 167 (81.9) 1.00 (ref.) 0.095
 High (3–4) 69 (24.7) 210 (75.3) 1.43 (1.00–2.04)
Type of fracture, n (%)
 Femur neck fracture 33 (11.7) 248 (88.3) 1.00 (ref.) <0.001
 Per-/subtrochanteric fracture 73 (34.8) 137 (65.2) 2.78 (1.96–3.94)
Hb on admission (n = 490), n (%)
 ≤110.0 g/l 48 (57.8) 35 (42.2) 1.00 (ref.) <0.001
 >110.0 g/l 58 (14.2) 349 (85.7) 0.24 (0.18–0.33)
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Mean decline in Hb from admission to lowest meas-
ured Hb was 24 g/l (±14) in patients who received ABT 
and 17  g/l (±10) in patients who did not. Patients with 
per-/subtrochanteric fractures received more often blood 
transfusion than femur neck fractures (Table 1). Patients 
with per-/subtrochanteric fractures (n = 206) had a sta-
tistically significant higher decline Hb from admission 
to first postoperative day than patients with femur neck 
fractures (n =  270), mean decline were 23 g/l (±12) vs. 
15 g/l (±10) p < 0.001.
Length of stay and mortality
Patients who came from a nursing home and received 
blood transfusion (n  =  23) stayed longer than nursing 
home patients who did not receive blood transfusion 
(n = 111), median 3 days (IQR 2, 5) vs. 2 days (IQR 1, 2), 
p < 0.001. Patients who were admitted from their homes 
and received blood transfusion (n  =  80) stayed 1  day 
longer compared to the same group of patients who did 
not receive blood transfusion (n =  269), median 8  days 
(IQR 6, 11) vs. 7 days (IQR 6, 9), p = 0.002. Neither ASA 
score nor number of chronic diseases accounted for this 
difference. When adjusted for number of complications, 
patients stayed on average 2 days longer if receiving ABT, 
and this did not differ according to whether they were 
admitted from nursing homes or from their own homes.
Prevalence and risk ratio of postoperative compli-
cations and mortality according to receiving ABT are 
shown in Table  2. Delirium, respiratory tract infections 
and urinary tract infections were associated with receiv-
ing ABT, while surgical wound infections were not. How-
ever, when adjusted for number of other complications, 
there was no statistically significant difference in preva-
lence of either of these complications.
We could not demonstrate any statistically significant 
difference in in-hospital or 30-days mortality between 
patients who received ABT and those who did not. How-
ever, 1-year mortality was higher in patients who received 
ABT (Table 2).
Discussion
We have described the temporal variations in Hb con-
centration and clinical characteristics of older hip frac-
ture patients according to whether they received ABT 
or not. Patients who received ABT had more often per-/
subtrochanteric fractures, were older, had more chronic 
diseases and had lower Hb at all measurements while 
hospitalized. Patients who received ABT had more com-
plications, stayed longer in hospital, and were more 
frequently discharged to nursing homes. There was no 
statistically significant difference in 30-days mortality 
between patients who received ABT and those who did 
not.
The general routine in our unit was to order ABT at Hb 
levels below 80  g/l regardless of time of measurement, 
or more liberally if the patient had symptoms of severe 
anemia (dizziness, exhaustion), delirium or heart disease. 
When given ABT 80 % had Hb <80 g/l and mean Hb was 
78  g/l. These results demonstrate a restrictive transfu-
sion policy in line with recent recommendations [11, 12], 
and a more restrictive policy compared to other centers, 
where 34–70 % received blood transfusions [6, 7, 18].
In this study Hb concentrations were measured on 
admission and on the first, third, and fifth postoperative 
day. Although the variation in Hb at all measuring points 
were substantial, Hb tended to decline until third post-
operative day and had stabilized on the fifth, 75 % of the 
transfusions were given during the first 3 days after sur-
gery. This is consistent with other findings and indicates 
Fig. 1 a Distribution of hemoglobin concentrations (g/l) on admis-
sion, day 1, 3 and 5 in patients who received ABT (n = 61). b Distribu-
tion of hemoglobin concentrations (g/l) on admission, day 1, 3 and 
5 in patients who did not received ABT (n = 152). Data restricted to 
patients with Hb measurements available at all four measurement 
points (n = 214). p < 0.001 between ABT recipients and non-recipi-
ents at all four time points
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that Hb in hip fracture patients should be monitored fre-
quently after surgery, in particular in per-/subtrochan-
teric fractures [19]. Time from the fracture to surgery 
may affect whether the patient will require blood transfu-
sion or not. In this study mean in-hospital waiting time 
to surgery was 16 h, and 82 % were operated within 24 h. 
This may explain why we found no relationship between 
time to surgery and administration of blood transfusion. 
However, the elapsed time from suffering the hip fracture 
until hospitalization is an unknown factor that may have 
contributed to the low Hb on admission. Only 17  % of 
the patients admitted from nursing homes received ABT. 
This may be due to the early discharge for these patients, 
as the mean LOS was 3 vs. 8 days for patients admitted 
from their own home. It has been proposed that a liberal 
transfusion policy may reduce the risk of readmission 
[19]. Whether this restrictive policy contributed to more 
readmissions is however not studied here.
ABT has been associated with an increased risk of infec-
tions [20]. Our data support an association between ABT 
and common medical complications (delirium, respiratory 
tract infections and urinary tract infections). However, 
it cannot be disentangled whether these complications 
are caused by the anemia, the comorbidities, or the ABT. 
We found no increased risk of surgical wound infections 
in ABT recipients, but this may be due to the low num-
ber of these infections. There was no statistically signifi-
cant difference in 30-days mortality in the two groups, but 
patients who received ABT had higher 1-year mortality. 
Studies show that Hb concentration on admission might 
be a predictor of mortality [21]. This might support the 
theory that the need for ABT in hip fracture patients is 
related to pre-fracture status as well as the type of fracture.
The strength of the study is that it included data on 
the total non-selected population of older hip fracture 
patients in our hospital. Patient subgroups commonly 
excluded from randomized controlled trials, such as 
patients with dementia and several co morbid conditions, 
were included. Important limitations are the missing val-
ues for Hb concentrations at first, third and fifth day for 
many patients, and the relatively low number of patients 
which might give underpowered results for some of the 
outcomes. The decline in Hb can therefore only be inter-
preted as a tendency. The Charlson´s Comorbidity Index 
has recently been shown to have limited ability as risk 
adjustment tool [22]. Finally, the study is only observa-
tional and from one hospital unit and the results cannot 
be used to give recommendations for transfusion policy 
or conclude on whether this transfusion policy is optimal.
Conclusion
Patients who were given ABT had a lower Hb on admis-
sion, had a larger decline in Hb and despite given ABT the 
Hb remained lower in Hb throughout hospital stay. The 
Hb in this study had a tendency to fall during the three 
first days after surgery and seemed to be stabilized on day 
5. The majority of patients who received ABT had per-/
subtrochanteric fracture and patients with these fractures 
should be observed closely regarding Hb concentrations.
Our results show a restrictive transfusion policy, and 
are in line with the routine to give blood transfusion at 
Hb levels below 80  g/l. Patients who received ABT are 
more prone to poor outcomes such as longer stay in hos-
pital and discharge to nursing homes.
Abbrevations
ABT: allogeninc red cell blood transfusion; ASA: american society of anesthe-
siologists score; CAM: confusion assessment method; Hb: hemoglobin G/l 
Grams per; liter LOS: length of stay.
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Table 2 Proportions and risk ratios of postoperative complications and case fatality according to receiving ABT in older 
hip fracture patients (n = 491)
a Chi square test or Fisher’s exact test for pressure ulcer, surgical wound infections, and in-hospital deaths due to small numbers
Received ABT  
(n = 106)
No ABT  
(n = 385)
Crude RR (95 % CI) of  
complications in ABT recipients
p valuea
Urinary tract infection, n (%) 24 (22.6) 55 (14.3) 1.58 (1.03–2.43) 0.035
Respiratory tract infection, n (%) 19 (17.9) 38 (9.9) 1.82 (1.09–3.02) 0.021
Delirium, n (%) 44 (41.5) 106 (27.5) 1.51 (1.14–1.99) 0.004
Cardio vascular complications 8 (7.5) 20 (5.2) 0.91 (0.45–1.83) 0.79
Pressure ulcer, n (%) 4 (3.8) 16 (4.2) 0.91 (0.31–2.66) 0.86
Surgical wound infection, n (%) 6 (5.7) 12 (3.1) 1.82 (0.70–4.72) 0.22
In-hospital case fatality, n (%) 3 (2.8) 5 (1.3) 2.18 (0.53–8.97) 0.28
30-day case fatality, n (%) 9 (8.5) 29 (7.5) 1.07 (0.52–2.20) 0.69
1-year case fatality, n (%) 40 (37.7) 97 (25.2) 1.50 (1.110–2.02) 0.008
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